These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 2226520)

  • 1. The role of oxidized low density lipoprotein in the pathogenesis of atherosclerosis.
    Kita T; Ishii K; Yokode M; Kume N; Nagano Y; Arai H; Kawai C
    Eur Heart J; 1990 Aug; 11 Suppl E():122-7. PubMed ID: 2226520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxidized lipoproteins in the pathogenesis of atherosclerosis.
    Kita T; Yokode M; Ishii K; Kume N; Nagano Y; Arai H; Otani H; Ueda Y; Hara S
    Clin Exp Pharmacol Physiol Suppl; 1992; 20():37-42. PubMed ID: 1446408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo inhibition of foam cell development by probucol in Watanabe rabbits.
    Steinberg D; Parthasarathy S; Carew TE
    Am J Cardiol; 1988 Jul; 62(3):6B-12B. PubMed ID: 3394654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of atherosclerotic progression in Watanabe rabbits by probucol.
    Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Narumiya S; Kawai C
    Am J Cardiol; 1988 Jul; 62(3):13B-19B. PubMed ID: 3394648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE; Schwenke DC; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of biologically modified low-density lipoprotein in atherosclerosis.
    Carew TE
    Am J Cardiol; 1989 Oct; 64(13):18G-22G. PubMed ID: 2679026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of atherosclerosis using an antioxidant].
    Ishii K; Kita T
    Nihon Ronen Igakkai Zasshi; 1990 Mar; 27(2):177-81. PubMed ID: 2384991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological modification of lipoproteins and its role in atherogenesis.
    Carew TE; Parthasarathy S
    Agents Actions Suppl; 1988; 26():191-200. PubMed ID: 3265277
    [No Abstract]   [Full Text] [Related]  

  • 9. Probucol does not affect lipoprotein metabolism in macrophages of Watanabe heritable hyperlipidemic rabbits.
    Nagano Y; Kita T; Yokode M; Ishii K; Kume N; Otani H; Arai H; Kawai C
    Arteriosclerosis; 1989; 9(4):453-61. PubMed ID: 2751475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of alpha-tocopherol, ubiquinone-10 and probucol at therapeutic doses on atherosclerosis in WHHL rabbits.
    Bräsen JH; Koenig K; Bach H; Kontush A; Heinle H; Witting PK; Ylä-Herttuala S; Stocker R; Beisiegel U
    Atherosclerosis; 2002 Aug; 163(2):249-59. PubMed ID: 12052471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia.
    Kita T; Nagano Y; Yokode M; Ishii K; Kume N; Ooshima A; Yoshida H; Kawai C
    Proc Natl Acad Sci U S A; 1987 Aug; 84(16):5928-31. PubMed ID: 3475709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Front line of oxidized lipoproteins: role of oxidized lipoproteins in atherogenesis and cardiovascular disease risk].
    Yoshida H
    Rinsho Byori; 2010 Jun; 58(6):622-30. PubMed ID: 20662275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.
    O'Brien K; Nagano Y; Gown A; Kita T; Chait A
    Arterioscler Thromb; 1991; 11(3):751-9. PubMed ID: 2029510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol inhibits oxidative modification of low density lipoprotein.
    Parthasarathy S; Young SG; Witztum JL; Pittman RC; Steinberg D
    J Clin Invest; 1986 Feb; 77(2):641-4. PubMed ID: 3944273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol protects lipoprotein (a) against oxidative modification.
    Naruszewicz M; Selinger E; Dufour R; Davignon J
    Metabolism; 1992 Nov; 41(11):1225-8. PubMed ID: 1435295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
    Kleinveld HA; Demacker PN; Stalenhoef AF
    Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
    Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
    J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits.
    Andersen HO; Holm P; Nordestgaard BG; Hansen BF; Kjeldsen K; Elinder LS; Stender S
    J Mol Cell Cardiol; 1995 Aug; 27(8):1561-71. PubMed ID: 8523419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits.
    Daugherty A; Zweifel BS; Schonfeld G
    Br J Pharmacol; 1991 May; 103(1):1013-8. PubMed ID: 1878742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.